Who
Amir F. Heshmatpour
CEO, President
Company insider
Files Form 4 as: CEO, President, NeOnc Technologies Holdings; President and Secretary, AFH Acquisition IX; Director and 10% owner, Bone Biologics.
In numbers
- Trades disclosed
- 55
- Buys
- 23
- Sells
- 3
- Bought
- $2.0M
- Sold
- $2.0M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 9 Oct 2015
- Last trade
- 15 Sep 2026
- Last filed
- 15 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 15 Sep 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $115K35,000 at $3.30 | filing |
| 15 Sep 2026filed 15 Sep 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $116K35,000 at $3.30 | filing |
| 14 Sep 2026filed 15 Sep 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $59K15,000 at $3.96 | filing |
| 14 Sep 2026filed 15 Sep 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $59K15,000 at $3.96 | filing |
| 11 Sep 2026filed 14 Sep 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $136K37,000 at $3.67 | filing |
| 11 Sep 2026filed 14 Sep 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $136K37,000 at $3.67 | filing |
| 18 Aug 2026filed 18 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $50K9,000 at $5.54 | filing |
| 18 Aug 2026filed 18 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $50K9,000 at $5.54 | filing |
| 17 Aug 2026filed 17 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $13K3,000 at $4.37 | filing |
| 17 Aug 2026filed 17 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $13K3,000 at $4.37 | filing |
| 14 Aug 2026filed 17 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $45K12,000 at $3.79 | filing |
| 14 Aug 2026filed 17 Aug 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $45K12,000 at $3.79 | filing |
| 1 May 2026filed 4 May 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $42K10,000 at $4.16 | filing |
| 1 May 2026filed 4 May 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $42K10,000 at $4.16 | filing |
| 28 Apr 2026filed 28 Apr 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $45K10,000 at $4.52 | filing |
| 28 Apr 2026filed 28 Apr 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $45K10,000 at $4.52 | filing |
| 23 Apr 2026filed 23 Apr 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $49K10,000 at $4.90 | filing |
| 23 Apr 2026filed 23 Apr 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $49K10,000 at $4.90 | filing |
| 10 Apr 2026filed 10 Apr 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $49K10,000 at $4.90 | filing |
| 10 Apr 2026filed 10 Apr 2026 | NTHI NeOnc Technologies HoldingsBiotechnology | SEC FORM 4 Bought | $49K10,000 at $4.90 | filing |
News
NeOnc CEO Amir F. Heshmatpour to Address Global Life Sciences Investment at Abu Dhabi Future Health Summit 2026manilatimes.net · 15 Oct 2026NeOnc Technologies and the Department of Health - Abu Dhabi Sign MoU to Advance Brain Cancer Research and Proposed Clinical CollaborationNTHI · manilatimes.net · 21 Oct 2026
1 headline in the last 90 days name Amir F. Heshmatpour; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.